Sign up
Quantellect · Congress · Trade Detail
NASDAQ: CMECME Group Inc
RepublicanSenate

John R. Curtis bought CME Group Inc (NASDAQ: CME)

John R. Curtis (R-UT), a U.S. Senator, has disclosed 2 trades in CME Group Inc (CME) since 2020, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: John R. Curtis bought $1,001 - $15,000 of CME Group Inc (NASDAQ: CME) on March 27, 2020. Since that trade, CME is up +97.21% against the S&P 500 up +213.14%, an outperformance of -115.93%.

Across these filings, John R. Curtis has been a balanced trader of CME (a buy-to-sell ratio of 1.00). The most recent disclosed CME transaction shown was dated June 22, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CME trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2020–2021

John R. Curtis's CME trades vs the price

CME is up +97.21% since John R. Curtis bought on March 27, 2020, versus +213.14% for the S&P 500.

Performance since this trade

Price change since trade
+97.21%
S&P 500 change since trade
+213.14%
Outperformance vs S&P 500
-115.93%

All John R. Curtis CME trades

TradedTypeSizeReturnEst. profit
June 22, 2021SELL$175.88+50.92%
March 27, 2020BUY$134.60+97.21%+$4K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John R. Curtis & CME trading FAQ

Is it legal for John R. Curtis to trade CME Group Inc (CME) stock?

Yes. Members of Congress are allowed to trade individual stocks, including CME Group Inc (CME), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John R. Curtis buy CME?

John R. Curtis disclosed a purchase of $1,001 - $15,000 of CME Group Inc (CME) on March 27, 2020, according to public STOCK Act filings.

How has CME performed since John R. Curtis's trade?

Since John R. Curtis bought CME on March 27, 2020, the stock is up +97.21%, versus +213.14% for the S&P 500 over the same period, an outperformance of -115.93%.

How many times has John R. Curtis traded CME?

John R. Curtis has disclosed 2 CME trades since 2020 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CME trades?

Quantellect tracks every disclosed congressional trade in CME Group Inc (CME) on the CME Group Inc congressional trading page, which aggregates filings across all members of Congress.

John R. Curtis's CME tradesAll congressional filings for CME Group IncJohn R. Curtis's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.